Table of Content

1 Study Coverage
1.1 Anti-CD31 Antibody Product Introduction
1.2 Market by Type
1.2.1 Global Anti-CD31 Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Market by Application
1.3.1 Global Anti-CD31 Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Immunochemistry
1.3.3 Immunofluorescence
1.3.4 Immunoprecipitation
1.3.5 Western Blot
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Anti-CD31 Antibody Sales Estimates and Forecasts 2018-2033
2.2 Global Anti-CD31 Antibody Revenue by Region
2.2.1 Global Anti-CD31 Antibody Revenue by Region: 2018 VS 2022 VS 2033
2.2.2 Global Anti-CD31 Antibody Revenue by Region (2018-2023)
2.2.3 Global Anti-CD31 Antibody Revenue by Region (2024-2033)
2.2.4 Global Anti-CD31 Antibody Revenue Market Share by Region (2018-2033)
2.3 Global Anti-CD31 Antibody Sales Estimates and Forecasts 2018-2033
2.4 Global Anti-CD31 Antibody Sales by Region
2.4.1 Global Anti-CD31 Antibody Sales by Region: 2018 VS 2022 VS 2033
2.4.2 Global Anti-CD31 Antibody Sales by Region (2018-2023)
2.4.3 Global Anti-CD31 Antibody Sales by Region (2024-2033)
2.4.4 Global Anti-CD31 Antibody Sales Market Share by Region (2018-2033)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Anti-CD31 Antibody Sales by Manufacturers
3.1.1 Global Anti-CD31 Antibody Sales by Manufacturers (2018-2023)
3.1.2 Global Anti-CD31 Antibody Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-CD31 Antibody in 2022
3.2 Global Anti-CD31 Antibody Revenue by Manufacturers
3.2.1 Global Anti-CD31 Antibody Revenue by Manufacturers (2018-2023)
3.2.2 Global Anti-CD31 Antibody Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Anti-CD31 Antibody Revenue in 2022
3.3 Global Key Players of Anti-CD31 Antibody, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Anti-CD31 Antibody Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Anti-CD31 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Anti-CD31 Antibody, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Anti-CD31 Antibody, Product Offered and Application
3.8 Global Key Manufacturers of Anti-CD31 Antibody, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anti-CD31 Antibody Sales by Type
4.1.1 Global Anti-CD31 Antibody Historical Sales by Type (2018-2023)
4.1.2 Global Anti-CD31 Antibody Forecasted Sales by Type (2024-2033)
4.1.3 Global Anti-CD31 Antibody Sales Market Share by Type (2018-2033)
4.2 Global Anti-CD31 Antibody Revenue by Type
4.2.1 Global Anti-CD31 Antibody Historical Revenue by Type (2018-2023)
4.2.2 Global Anti-CD31 Antibody Forecasted Revenue by Type (2024-2033)
4.2.3 Global Anti-CD31 Antibody Revenue Market Share by Type (2018-2033)
4.3 Global Anti-CD31 Antibody Price by Type
4.3.1 Global Anti-CD31 Antibody Price by Type (2018-2023)
4.3.2 Global Anti-CD31 Antibody Price Forecast by Type (2024-2033)
5 Market Size by Application
5.1 Global Anti-CD31 Antibody Sales by Application
5.1.1 Global Anti-CD31 Antibody Historical Sales by Application (2018-2023)
5.1.2 Global Anti-CD31 Antibody Forecasted Sales by Application (2024-2033)
5.1.3 Global Anti-CD31 Antibody Sales Market Share by Application (2018-2033)
5.2 Global Anti-CD31 Antibody Revenue by Application
5.2.1 Global Anti-CD31 Antibody Historical Revenue by Application (2018-2023)
5.2.2 Global Anti-CD31 Antibody Forecasted Revenue by Application (2024-2033)
5.2.3 Global Anti-CD31 Antibody Revenue Market Share by Application (2018-2033)
5.3 Global Anti-CD31 Antibody Price by Application
5.3.1 Global Anti-CD31 Antibody Price by Application (2018-2023)
5.3.2 Global Anti-CD31 Antibody Price Forecast by Application (2024-2033)
6 US & Canada
6.1 US & Canada Anti-CD31 Antibody Market Size by Type
6.1.1 US & Canada Anti-CD31 Antibody Sales by Type (2018-2033)
6.1.2 US & Canada Anti-CD31 Antibody Revenue by Type (2018-2033)
6.2 US & Canada Anti-CD31 Antibody Market Size by Application
6.2.1 US & Canada Anti-CD31 Antibody Sales by Application (2018-2033)
6.2.2 US & Canada Anti-CD31 Antibody Revenue by Application (2018-2033)
6.3 US & Canada Anti-CD31 Antibody Market Size by Country
6.3.1 US & Canada Anti-CD31 Antibody Revenue by Country: 2018 VS 2022 VS 2033
6.3.2 US & Canada Anti-CD31 Antibody Sales by Country (2018-2033)
6.3.3 US & Canada Anti-CD31 Antibody Revenue by Country (2018-2033)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Anti-CD31 Antibody Market Size by Type
7.1.1 Europe Anti-CD31 Antibody Sales by Type (2018-2033)
7.1.2 Europe Anti-CD31 Antibody Revenue by Type (2018-2033)
7.2 Europe Anti-CD31 Antibody Market Size by Application
7.2.1 Europe Anti-CD31 Antibody Sales by Application (2018-2033)
7.2.2 Europe Anti-CD31 Antibody Revenue by Application (2018-2033)
7.3 Europe Anti-CD31 Antibody Market Size by Country
7.3.1 Europe Anti-CD31 Antibody Revenue by Country: 2018 VS 2022 VS 2033
7.3.2 Europe Anti-CD31 Antibody Sales by Country (2018-2033)
7.3.3 Europe Anti-CD31 Antibody Revenue by Country (2018-2033)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Anti-CD31 Antibody Market Size
8.1.1 China Anti-CD31 Antibody Sales (2018-2033)
8.1.2 China Anti-CD31 Antibody Revenue (2018-2033)
8.2 China Anti-CD31 Antibody Market Size by Application
8.2.1 China Anti-CD31 Antibody Sales by Application (2018-2033)
8.2.2 China Anti-CD31 Antibody Revenue by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Anti-CD31 Antibody Market Size by Type
9.1.1 Asia Anti-CD31 Antibody Sales by Type (2018-2033)
9.1.2 Asia Anti-CD31 Antibody Revenue by Type (2018-2033)
9.2 Asia Anti-CD31 Antibody Market Size by Application
9.2.1 Asia Anti-CD31 Antibody Sales by Application (2018-2033)
9.2.2 Asia Anti-CD31 Antibody Revenue by Application (2018-2033)
9.3 Asia Anti-CD31 Antibody Sales by Region
9.3.1 Asia Anti-CD31 Antibody Revenue by Region: 2018 VS 2022 VS 2033
9.3.2 Asia Anti-CD31 Antibody Revenue by Region (2018-2033)
9.3.3 Asia Anti-CD31 Antibody Sales by Region (2018-2033)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Anti-CD31 Antibody Market Size by Type
10.1.1 Middle East, Africa and Latin America Anti-CD31 Antibody Sales by Type (2018-2033)
10.1.2 Middle East, Africa and Latin America Anti-CD31 Antibody Revenue by Type (2018-2033)
10.2 Middle East, Africa and Latin America Anti-CD31 Antibody Market Size by Application
10.2.1 Middle East, Africa and Latin America Anti-CD31 Antibody Sales by Application (2018-2033)
10.2.2 Middle East, Africa and Latin America Anti-CD31 Antibody Revenue by Application (2018-2033)
10.3 Middle East, Africa and Latin America Anti-CD31 Antibody Sales by Country
10.3.1 Middle East, Africa and Latin America Anti-CD31 Antibody Revenue by Country: 2018 VS 2022 VS 2033
10.3.2 Middle East, Africa and Latin America Anti-CD31 Antibody Revenue by Country (2018-2033)
10.3.3 Middle East, Africa and Latin America Anti-CD31 Antibody Sales by Country (2018-2033)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 BosterBio
11.1.1 BosterBio Company Information
11.1.2 BosterBio Overview
11.1.3 BosterBio Anti-CD31 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 BosterBio Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 BosterBio Recent Developments
11.2 Bio-Rad
11.2.1 Bio-Rad Company Information
11.2.2 Bio-Rad Overview
11.2.3 Bio-Rad Anti-CD31 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Bio-Rad Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bio-Rad Recent Developments
11.3 BD Biosciences
11.3.1 BD Biosciences Company Information
11.3.2 BD Biosciences Overview
11.3.3 BD Biosciences Anti-CD31 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 BD Biosciences Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 BD Biosciences Recent Developments
11.4 Abcam
11.4.1 Abcam Company Information
11.4.2 Abcam Overview
11.4.3 Abcam Anti-CD31 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Abcam Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Abcam Recent Developments
11.5 RayBiotech
11.5.1 RayBiotech Company Information
11.5.2 RayBiotech Overview
11.5.3 RayBiotech Anti-CD31 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 RayBiotech Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 RayBiotech Recent Developments
11.6 GeneTex
11.6.1 GeneTex Company Information
11.6.2 GeneTex Overview
11.6.3 GeneTex Anti-CD31 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 GeneTex Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GeneTex Recent Developments
11.7 BioLegend
11.7.1 BioLegend Company Information
11.7.2 BioLegend Overview
11.7.3 BioLegend Anti-CD31 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 BioLegend Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 BioLegend Recent Developments
11.8 BMA Biomedicals
11.8.1 BMA Biomedicals Company Information
11.8.2 BMA Biomedicals Overview
11.8.3 BMA Biomedicals Anti-CD31 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 BMA Biomedicals Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 BMA Biomedicals Recent Developments
11.9 Bethyl Laboratories
11.9.1 Bethyl Laboratories Company Information
11.9.2 Bethyl Laboratories Overview
11.9.3 Bethyl Laboratories Anti-CD31 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Bethyl Laboratories Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Bethyl Laboratories Recent Developments
11.10 SouthernBiotech
11.10.1 SouthernBiotech Company Information
11.10.2 SouthernBiotech Overview
11.10.3 SouthernBiotech Anti-CD31 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 SouthernBiotech Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 SouthernBiotech Recent Developments
11.11 Elabscience Biotechnology Inc
11.11.1 Elabscience Biotechnology Inc Company Information
11.11.2 Elabscience Biotechnology Inc Overview
11.11.3 Elabscience Biotechnology Inc Anti-CD31 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Elabscience Biotechnology Inc Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Elabscience Biotechnology Inc Recent Developments
11.12 Merck
11.12.1 Merck Company Information
11.12.2 Merck Overview
11.12.3 Merck Anti-CD31 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 Merck Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Merck Recent Developments
11.13 Leica Biosystems
11.13.1 Leica Biosystems Company Information
11.13.2 Leica Biosystems Overview
11.13.3 Leica Biosystems Anti-CD31 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Leica Biosystems Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Leica Biosystems Recent Developments
11.14 Beijing Solarbio Science & Technology
11.14.1 Beijing Solarbio Science & Technology Company Information
11.14.2 Beijing Solarbio Science & Technology Overview
11.14.3 Beijing Solarbio Science & Technology Anti-CD31 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 Beijing Solarbio Science & Technology Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Beijing Solarbio Science & Technology Recent Developments
11.15 Wuhan Fine Biotech
11.15.1 Wuhan Fine Biotech Company Information
11.15.2 Wuhan Fine Biotech Overview
11.15.3 Wuhan Fine Biotech Anti-CD31 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.15.4 Wuhan Fine Biotech Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Wuhan Fine Biotech Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Anti-CD31 Antibody Industry Chain Analysis
12.2 Anti-CD31 Antibody Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anti-CD31 Antibody Production Mode & Process
12.4 Anti-CD31 Antibody Sales and Marketing
12.4.1 Anti-CD31 Antibody Sales Channels
12.4.2 Anti-CD31 Antibody Distributors
12.5 Anti-CD31 Antibody Customers
13 Market Dynamics
13.1 Anti-CD31 Antibody Industry Trends
13.2 Anti-CD31 Antibody Market Drivers
13.3 Anti-CD31 Antibody Market Challenges
13.4 Anti-CD31 Antibody Market Restraints
14 Key Findings in The Global Anti-CD31 Antibody Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Anti-CD31 Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Table 2. Major Manufacturers of Monoclonal
Table 3. Major Manufacturers of Polyclonal
Table 4. Global Anti-CD31 Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Table 5. Global Anti-CD31 Antibody Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 6. Global Anti-CD31 Antibody Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Anti-CD31 Antibody Revenue by Region (2024-2033) & (US$ Million)
Table 8. Global Anti-CD31 Antibody Revenue Market Share by Region (2018-2023)
Table 9. Global Anti-CD31 Antibody Revenue Market Share by Region (2024-2033)
Table 10. Global Anti-CD31 Antibody Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 11. Global Anti-CD31 Antibody Sales by Region (2018-2023) & (K Units)
Table 12. Global Anti-CD31 Antibody Sales by Region (2024-2033) & (K Units)
Table 13. Global Anti-CD31 Antibody Sales Market Share by Region (2018-2023)
Table 14. Global Anti-CD31 Antibody Sales Market Share by Region (2024-2033)
Table 15. Global Anti-CD31 Antibody Sales by Manufacturers (2018-2023) & (K Units)
Table 16. Global Anti-CD31 Antibody Sales Share by Manufacturers (2018-2023)
Table 17. Global Anti-CD31 Antibody Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Anti-CD31 Antibody Revenue Share by Manufacturers (2018-2023)
Table 19. Global Key Players of Anti-CD31 Antibody, Industry Ranking, 2021 VS 2022 VS 2023
Table 20. Anti-CD31 Antibody Price by Manufacturers 2018-2023 (US$/Unit)
Table 21. Global Anti-CD31 Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Anti-CD31 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-CD31 Antibody as of 2022)
Table 23. Global Key Manufacturers of Anti-CD31 Antibody, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Anti-CD31 Antibody, Product Offered and Application
Table 25. Global Key Manufacturers of Anti-CD31 Antibody, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Anti-CD31 Antibody Sales by Type (2018-2023) & (K Units)
Table 28. Global Anti-CD31 Antibody Sales by Type (2024-2033) & (K Units)
Table 29. Global Anti-CD31 Antibody Sales Share by Type (2018-2023)
Table 30. Global Anti-CD31 Antibody Sales Share by Type (2024-2033)
Table 31. Global Anti-CD31 Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Anti-CD31 Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 33. Global Anti-CD31 Antibody Revenue Share by Type (2018-2023)
Table 34. Global Anti-CD31 Antibody Revenue Share by Type (2024-2033)
Table 35. Anti-CD31 Antibody Price by Type (2018-2023) & (US$/Unit)
Table 36. Global Anti-CD31 Antibody Price Forecast by Type (2024-2033) & (US$/Unit)
Table 37. Global Anti-CD31 Antibody Sales by Application (2018-2023) & (K Units)
Table 38. Global Anti-CD31 Antibody Sales by Application (2024-2033) & (K Units)
Table 39. Global Anti-CD31 Antibody Sales Share by Application (2018-2023)
Table 40. Global Anti-CD31 Antibody Sales Share by Application (2024-2033)
Table 41. Global Anti-CD31 Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Anti-CD31 Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 43. Global Anti-CD31 Antibody Revenue Share by Application (2018-2023)
Table 44. Global Anti-CD31 Antibody Revenue Share by Application (2024-2033)
Table 45. Anti-CD31 Antibody Price by Application (2018-2023) & (US$/Unit)
Table 46. Global Anti-CD31 Antibody Price Forecast by Application (2024-2033) & (US$/Unit)
Table 47. US & Canada Anti-CD31 Antibody Sales by Type (2018-2023) & (K Units)
Table 48. US & Canada Anti-CD31 Antibody Sales by Type (2024-2033) & (K Units)
Table 49. US & Canada Anti-CD31 Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 50. US & Canada Anti-CD31 Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 51. US & Canada Anti-CD31 Antibody Sales by Application (2018-2023) & (K Units)
Table 52. US & Canada Anti-CD31 Antibody Sales by Application (2024-2033) & (K Units)
Table 53. US & Canada Anti-CD31 Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 54. US & Canada Anti-CD31 Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 55. US & Canada Anti-CD31 Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 56. US & Canada Anti-CD31 Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 57. US & Canada Anti-CD31 Antibody Revenue by Country (2024-2033) & (US$ Million)
Table 58. US & Canada Anti-CD31 Antibody Sales by Country (2018-2023) & (K Units)
Table 59. US & Canada Anti-CD31 Antibody Sales by Country (2024-2033) & (K Units)
Table 60. Europe Anti-CD31 Antibody Sales by Type (2018-2023) & (K Units)
Table 61. Europe Anti-CD31 Antibody Sales by Type (2024-2033) & (K Units)
Table 62. Europe Anti-CD31 Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 63. Europe Anti-CD31 Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 64. Europe Anti-CD31 Antibody Sales by Application (2018-2023) & (K Units)
Table 65. Europe Anti-CD31 Antibody Sales by Application (2024-2033) & (K Units)
Table 66. Europe Anti-CD31 Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 67. Europe Anti-CD31 Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 68. Europe Anti-CD31 Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 69. Europe Anti-CD31 Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 70. Europe Anti-CD31 Antibody Revenue by Country (2024-2033) & (US$ Million)
Table 71. Europe Anti-CD31 Antibody Sales by Country (2018-2023) & (K Units)
Table 72. Europe Anti-CD31 Antibody Sales by Country (2024-2033) & (K Units)
Table 73. China Anti-CD31 Antibody Sales by Type (2018-2023) & (K Units)
Table 74. China Anti-CD31 Antibody Sales by Type (2024-2033) & (K Units)
Table 75. China Anti-CD31 Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 76. China Anti-CD31 Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 77. China Anti-CD31 Antibody Sales by Application (2018-2023) & (K Units)
Table 78. China Anti-CD31 Antibody Sales by Application (2024-2033) & (K Units)
Table 79. China Anti-CD31 Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 80. China Anti-CD31 Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 81. Asia Anti-CD31 Antibody Sales by Type (2018-2023) & (K Units)
Table 82. Asia Anti-CD31 Antibody Sales by Type (2024-2033) & (K Units)
Table 83. Asia Anti-CD31 Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 84. Asia Anti-CD31 Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 85. Asia Anti-CD31 Antibody Sales by Application (2018-2023) & (K Units)
Table 86. Asia Anti-CD31 Antibody Sales by Application (2024-2033) & (K Units)
Table 87. Asia Anti-CD31 Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 88. Asia Anti-CD31 Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 89. Asia Anti-CD31 Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 90. Asia Anti-CD31 Antibody Revenue by Region (2018-2023) & (US$ Million)
Table 91. Asia Anti-CD31 Antibody Revenue by Region (2024-2033) & (US$ Million)
Table 92. Asia Anti-CD31 Antibody Sales by Region (2018-2023) & (K Units)
Table 93. Asia Anti-CD31 Antibody Sales by Region (2024-2033) & (K Units)
Table 94. Middle East, Africa and Latin America Anti-CD31 Antibody Sales by Type (2018-2023) & (K Units)
Table 95. Middle East, Africa and Latin America Anti-CD31 Antibody Sales by Type (2024-2033) & (K Units)
Table 96. Middle East, Africa and Latin America Anti-CD31 Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 97. Middle East, Africa and Latin America Anti-CD31 Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 98. Middle East, Africa and Latin America Anti-CD31 Antibody Sales by Application (2018-2023) & (K Units)
Table 99. Middle East, Africa and Latin America Anti-CD31 Antibody Sales by Application (2024-2033) & (K Units)
Table 100. Middle East, Africa and Latin America Anti-CD31 Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Anti-CD31 Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 102. Middle East, Africa and Latin America Anti-CD31 Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 103. Middle East, Africa and Latin America Anti-CD31 Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Anti-CD31 Antibody Revenue by Country (2024-2033) & (US$ Million)
Table 105. Middle East, Africa and Latin America Anti-CD31 Antibody Sales by Country (2018-2023) & (K Units)
Table 106. Middle East, Africa and Latin America Anti-CD31 Antibody Sales by Country (2024-2033) & (K Units)
Table 107. BosterBio Company Information
Table 108. BosterBio Description and Major Businesses
Table 109. BosterBio Anti-CD31 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. BosterBio Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. BosterBio Recent Developments
Table 112. Bio-Rad Company Information
Table 113. Bio-Rad Description and Major Businesses
Table 114. Bio-Rad Anti-CD31 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Bio-Rad Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Bio-Rad Recent Developments
Table 117. BD Biosciences Company Information
Table 118. BD Biosciences Description and Major Businesses
Table 119. BD Biosciences Anti-CD31 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. BD Biosciences Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. BD Biosciences Recent Developments
Table 122. Abcam Company Information
Table 123. Abcam Description and Major Businesses
Table 124. Abcam Anti-CD31 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. Abcam Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Abcam Recent Developments
Table 127. RayBiotech Company Information
Table 128. RayBiotech Description and Major Businesses
Table 129. RayBiotech Anti-CD31 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 130. RayBiotech Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. RayBiotech Recent Developments
Table 132. GeneTex Company Information
Table 133. GeneTex Description and Major Businesses
Table 134. GeneTex Anti-CD31 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 135. GeneTex Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. GeneTex Recent Developments
Table 137. BioLegend Company Information
Table 138. BioLegend Description and Major Businesses
Table 139. BioLegend Anti-CD31 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 140. BioLegend Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. BioLegend Recent Developments
Table 142. BMA Biomedicals Company Information
Table 143. BMA Biomedicals Description and Major Businesses
Table 144. BMA Biomedicals Anti-CD31 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 145. BMA Biomedicals Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. BMA Biomedicals Recent Developments
Table 147. Bethyl Laboratories Company Information
Table 148. Bethyl Laboratories Description and Major Businesses
Table 149. Bethyl Laboratories Anti-CD31 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 150. Bethyl Laboratories Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Bethyl Laboratories Recent Developments
Table 152. SouthernBiotech Company Information
Table 153. SouthernBiotech Description and Major Businesses
Table 154. SouthernBiotech Anti-CD31 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 155. SouthernBiotech Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. SouthernBiotech Recent Developments
Table 157. Elabscience Biotechnology Inc Company Information
Table 158. Elabscience Biotechnology Inc Description and Major Businesses
Table 159. Elabscience Biotechnology Inc Anti-CD31 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 160. Elabscience Biotechnology Inc Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Elabscience Biotechnology Inc Recent Developments
Table 162. Merck Company Information
Table 163. Merck Description and Major Businesses
Table 164. Merck Anti-CD31 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 165. Merck Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Merck Recent Developments
Table 167. Leica Biosystems Company Information
Table 168. Leica Biosystems Description and Major Businesses
Table 169. Leica Biosystems Anti-CD31 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 170. Leica Biosystems Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Leica Biosystems Recent Developments
Table 172. Beijing Solarbio Science & Technology Company Information
Table 173. Beijing Solarbio Science & Technology Description and Major Businesses
Table 174. Beijing Solarbio Science & Technology Anti-CD31 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 175. Beijing Solarbio Science & Technology Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Beijing Solarbio Science & Technology Recent Developments
Table 177. Wuhan Fine Biotech Company Information
Table 178. Wuhan Fine Biotech Description and Major Businesses
Table 179. Wuhan Fine Biotech Anti-CD31 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 180. Wuhan Fine Biotech Anti-CD31 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Wuhan Fine Biotech Recent Developments
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Anti-CD31 Antibody Distributors List
Table 185. Anti-CD31 Antibody Customers List
Table 186. Anti-CD31 Antibody Market Trends
Table 187. Anti-CD31 Antibody Market Drivers
Table 188. Anti-CD31 Antibody Market Challenges
Table 189. Anti-CD31 Antibody Market Restraints
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-CD31 Antibody Product Picture
Figure 2. Global Anti-CD31 Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 3. Global Anti-CD31 Antibody Market Share by Type in 2022 & 2033
Figure 4. Monoclonal Product Picture
Figure 5. Polyclonal Product Picture
Figure 6. Global Anti-CD31 Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global Anti-CD31 Antibody Market Share by Application in 2022 & 2033
Figure 8. Immunochemistry
Figure 9. Immunofluorescence
Figure 10. Immunoprecipitation
Figure 11. Western Blot
Figure 12. Others
Figure 13. Anti-CD31 Antibody Report Years Considered
Figure 14. Global Anti-CD31 Antibody Revenue, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Anti-CD31 Antibody Revenue 2018-2033 (US$ Million)
Figure 16. Global Anti-CD31 Antibody Revenue Market Share by Region in Percentage: 2022 Versus 2033
Figure 17. Global Anti-CD31 Antibody Revenue Market Share by Region (2018-2033)
Figure 18. Global Anti-CD31 Antibody Sales 2018-2033 ((K Units)
Figure 19. Global Anti-CD31 Antibody Sales Market Share by Region (2018-2033)
Figure 20. US & Canada Anti-CD31 Antibody Sales YoY (2018-2033) & (K Units)
Figure 21. US & Canada Anti-CD31 Antibody Revenue YoY (2018-2033) & (US$ Million)
Figure 22. Europe Anti-CD31 Antibody Sales YoY (2018-2033) & (K Units)
Figure 23. Europe Anti-CD31 Antibody Revenue YoY (2018-2033) & (US$ Million)
Figure 24. China Anti-CD31 Antibody Sales YoY (2018-2033) & (K Units)
Figure 25. China Anti-CD31 Antibody Revenue YoY (2018-2033) & (US$ Million)
Figure 26. Asia (excluding China) Anti-CD31 Antibody Sales YoY (2018-2033) & (K Units)
Figure 27. Asia (excluding China) Anti-CD31 Antibody Revenue YoY (2018-2033) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Anti-CD31 Antibody Sales YoY (2018-2033) & (K Units)
Figure 29. Middle East, Africa and Latin America Anti-CD31 Antibody Revenue YoY (2018-2033) & (US$ Million)
Figure 30. The Anti-CD31 Antibody Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Anti-CD31 Antibody in the World: Market Share by Anti-CD31 Antibody Revenue in 2022
Figure 32. Global Anti-CD31 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Anti-CD31 Antibody Sales Market Share by Type (2018-2033)
Figure 34. Global Anti-CD31 Antibody Revenue Market Share by Type (2018-2033)
Figure 35. Global Anti-CD31 Antibody Sales Market Share by Application (2018-2033)
Figure 36. Global Anti-CD31 Antibody Revenue Market Share by Application (2018-2033)
Figure 37. US & Canada Anti-CD31 Antibody Sales Market Share by Type (2018-2033)
Figure 38. US & Canada Anti-CD31 Antibody Revenue Market Share by Type (2018-2033)
Figure 39. US & Canada Anti-CD31 Antibody Sales Market Share by Application (2018-2033)
Figure 40. US & Canada Anti-CD31 Antibody Revenue Market Share by Application (2018-2033)
Figure 41. US & Canada Anti-CD31 Antibody Revenue Share by Country (2018-2033)
Figure 42. US & Canada Anti-CD31 Antibody Sales Share by Country (2018-2033)
Figure 43. U.S. Anti-CD31 Antibody Revenue (2018-2033) & (US$ Million)
Figure 44. Canada Anti-CD31 Antibody Revenue (2018-2033) & (US$ Million)
Figure 45. Europe Anti-CD31 Antibody Sales Market Share by Type (2018-2033)
Figure 46. Europe Anti-CD31 Antibody Revenue Market Share by Type (2018-2033)
Figure 47. Europe Anti-CD31 Antibody Sales Market Share by Application (2018-2033)
Figure 48. Europe Anti-CD31 Antibody Revenue Market Share by Application (2018-2033)
Figure 49. Europe Anti-CD31 Antibody Revenue Share by Country (2018-2033)
Figure 50. Europe Anti-CD31 Antibody Sales Share by Country (2018-2033)
Figure 51. Germany Anti-CD31 Antibody Revenue (2018-2033) & (US$ Million)
Figure 52. France Anti-CD31 Antibody Revenue (2018-2033) & (US$ Million)
Figure 53. U.K. Anti-CD31 Antibody Revenue (2018-2033) & (US$ Million)
Figure 54. Italy Anti-CD31 Antibody Revenue (2018-2033) & (US$ Million)
Figure 55. Russia Anti-CD31 Antibody Revenue (2018-2033) & (US$ Million)
Figure 56. China Anti-CD31 Antibody Sales Market Share by Type (2018-2033)
Figure 57. China Anti-CD31 Antibody Revenue Market Share by Type (2018-2033)
Figure 58. China Anti-CD31 Antibody Sales Market Share by Application (2018-2033)
Figure 59. China Anti-CD31 Antibody Revenue Market Share by Application (2018-2033)
Figure 60. Asia Anti-CD31 Antibody Sales Market Share by Type (2018-2033)
Figure 61. Asia Anti-CD31 Antibody Revenue Market Share by Type (2018-2033)
Figure 62. Asia Anti-CD31 Antibody Sales Market Share by Application (2018-2033)
Figure 63. Asia Anti-CD31 Antibody Revenue Market Share by Application (2018-2033)
Figure 64. Asia Anti-CD31 Antibody Revenue Share by Region (2018-2033)
Figure 65. Asia Anti-CD31 Antibody Sales Share by Region (2018-2033)
Figure 66. Japan Anti-CD31 Antibody Revenue (2018-2033) & (US$ Million)
Figure 67. South Korea Anti-CD31 Antibody Revenue (2018-2033) & (US$ Million)
Figure 68. China Taiwan Anti-CD31 Antibody Revenue (2018-2033) & (US$ Million)
Figure 69. Southeast Asia Anti-CD31 Antibody Revenue (2018-2033) & (US$ Million)
Figure 70. India Anti-CD31 Antibody Revenue (2018-2033) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Anti-CD31 Antibody Sales Market Share by Type (2018-2033)
Figure 72. Middle East, Africa and Latin America Anti-CD31 Antibody Revenue Market Share by Type (2018-2033)
Figure 73. Middle East, Africa and Latin America Anti-CD31 Antibody Sales Market Share by Application (2018-2033)
Figure 74. Middle East, Africa and Latin America Anti-CD31 Antibody Revenue Market Share by Application (2018-2033)
Figure 75. Middle East, Africa and Latin America Anti-CD31 Antibody Revenue Share by Country (2018-2033)
Figure 76. Middle East, Africa and Latin America Anti-CD31 Antibody Sales Share by Country (2018-2033)
Figure 77. Brazil Anti-CD31 Antibody Revenue (2018-2033) & (US$ Million)
Figure 78. Mexico Anti-CD31 Antibody Revenue (2018-2033) & (US$ Million)
Figure 79. Turkey Anti-CD31 Antibody Revenue (2018-2033) & (US$ Million)
Figure 80. Israel Anti-CD31 Antibody Revenue (2018-2033) & (US$ Million)
Figure 81. GCC Countries Anti-CD31 Antibody Revenue (2018-2033) & (US$ Million)
Figure 82. Anti-CD31 Antibody Value Chain
Figure 83. Anti-CD31 Antibody Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed